Regulatory Approach for Biosimilars
Biosimilars are the generic version of biological. It is the new buzz word in pharmaceutical industry. Biosimilars are highly similar to licensed reference product not withstanding minor differences in clinically inactive components; also there are no clinically meaningful differences between the biologicals and the reference product in terms of safety, purity, and potency. This track includes: Licensing of biosimilars, Biosimilars regulation, Patent issues, BLA filing for biosimilars, Biosimilars regulatory prospects of BRIC countries, a paradigm of traditional generics to Biosimilars, Biowaiver approval for Biosimilars and other aspects of Biosimilar approvals. Biosimilars 2018 will provide an excellent and global opportunity to the scientists, partners and pharma leaders from Biopharmaceutical and Biotechnology industries to innovate and to explore the strategic market for Biosimilars and Biologics with a clear picture of the regulatory approach for biosimilars and biologics.
- Licensing of biosimilars
- Biosimilars regulation
- BLA filing for biosimilars
- Regulatory prospects of BRIC countries
- A paradigm of traditional generics to biosimilars
- Biowaiver approval for Biosimilars
- Generic Biosimilars
- BLA filing for biosimilars
Related Conference of Regulatory Approach for Biosimilars
February 27-28, 2025
8th International on Pharmacy and Pharmaceutical Conference
Prague, Czech Republic
April 07-08, 2025
4th International Conference and Expo on Pharmaceutics & Novel Drug Delivery Systems
Vancouver, Canada
May 05-06, 2025
17th International Conference on Pharmaceutical Education and Practice
Vancouver, Canada
June 02-03, 2025
31st International Conference on Advanced Clinical Research and Clinical Trials
Amsterdam, Netherlands
June 10-11, 2025
24th International Conference on Medicinal and Pharmaceutical Chemistry
Vancouver, Canada
June 10-11, 2025
7th International Conference and Exhibition on Pharmaceutical Development and Technology
Vancouver, Canada
June 16-17, 2025
18th International Conference and Exhibition on Pharmacovigilance & Drug Safety
Frankfurt, Germany
June 23-24, 2025
25th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry
Paris, France
September 08-09, 2025
26th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems
Frankfurt, Germany
September 23-24, 2025
10th International Conference on Future Pharma and Innovations
Amsterdam, Netherlands
November 27-28, 2025
4th World Conference on Pharma Industry and Medical Devices
Zurich, Switzerland
Regulatory Approach for Biosimilars Conference Speakers
Recommended Sessions
- BCS and IVIVC Based Biowaivers
- Bioequivalence Assessment
- Biopharmaceuticals
- Biosimilars Development
- Biosimilars in Oncology
- Biosimilars in Therapeutics
- Biosimilars Pipeline
- Challenges in Pharmacovigilance
- Clinical Trials of Biosimilars
- Drug Development and Delivery
- Globalization of Biosimilars
- Intellectual Property Rights
- Legal Issues and BPCI Acts
- Regulatory Approach for Biosimilars
Related Journals
Are you interested in
- 3D Printing of Drugs - PHARMA CONFERENCE-2025 (France)
- Active Pharmaceutical Ingredients - MedTech-2025 (Switzerland)
- Adaptive Trial Models in Research - Clinical Trials Congress-2025 (France)
- Advanced Analytical Techniques in Drug Development - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Advanced Drug Delivery Systems - PHARMA CONFERENCE-2025 (France)
- Advancements in drug delivery systems - Pharmaceutica-2025 (Canada)
- Advancements in Pharmacovigilance - Clinical Trials Congress-2025 (France)
- Advances in Cardiovascular Drug Discovery - Cardiovascular-2025 (France)
- Advances in Controlled Release Formulations - Pharmaceutica-2025 (Canada)
- Advances in Drug Discovery - Clinical Trials Congress-2025 (France)
- Advances in Internal Medicine - Pain Management 2025 (Switzerland)
- Advances in Pharmaceutical Packaging - PHARMACEUTICAL SCIENCES 2025 (France)
- Adverse Drug Reactions - PHARMACOVIGILANCE 2025 (Germany)
- Adverse Drug Reactions - Pharmacology 2025 (France)
- Analytical Biotechnology - Biotech-2025 (France)
- Analytical Chemistry - PHARMAKON 2025 (Spain)
- Analytical strategies for pharmaceutical products - MedTech-2025 (Switzerland)
- Anesthesia and Critical Care - Pain Management 2025 (Switzerland)
- Antibiotics - PHARMAKON 2025 (Spain)
- Application of Pharmacology in Medical Science - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Applied Medicinal Chemistry - PHARMAKON 2025 (Spain)
- Applied Microbiology - Biotech-2025 (France)
- Artificial Intelligence (AI) - Personalizedmedicine-2025 (Switzerland)
- Artificial Intelligence and Machine Learning in Drug Delivery Optimization - Pharmaceutica-2025 (Canada)
- Artificial Intelligence and Machine Learning in Pharmaceutical Chemistry - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Artificial Intelligence in Drug Discovery - PHARMA CONFERENCE-2025 (France)
- BCS and IVIVC Based Biowaivers - Eurobiosimilars 2025 (France)
- Big data analytics and Pharma - Future Pharma 2025 (Netherlands)
- Bio Chemical Pharmacology - Pharmacology 2025 (France)
- Bio Molecular Dynamics - Biotech-2025 (France)
- Bio-Organic Chemistry - PHARMAKON 2025 (Spain)
- Bio-Pharmaceutics - PHARMACEUTICA 2025 (Germany)
- Bioequivalence and Bioavailability - MedTech-2025 (Switzerland)
- Bioinformatics - Pharma Europe 2025 (Italy)
- Bioisosteres - PHARMAKON 2025 (Spain)
- Biological Drugs in Autoimmune Diseases - PHARMAKON 2025 (Spain)
- Biological Medicine - Eurobiosimilars 2025 (France)
- Biologics & Biosimilars - PHARMACEUTICA 2025 (Germany)
- Biologics and Biosimilars - Pharmaceutica-2025 (Canada)
- Biologics and Biosimilars - PHARMA CONFERENCE-2025 (France)
- Biomarker Discovery in Drug Development - Clinical Trials Congress-2025 (France)
- Biomarkers - Personalizedmedicine-2025 (Switzerland)
- Biomarkers in Cardiovascular Disease and Drug Response - Cardiovascular-2025 (France)
- Biomaterials in Drug Delivery - PHARMACEUTICA 2025 (Germany)
- Biopharmaceutical Informatics - Eurobiosimilars 2025 (France)
- Biopharmaceutical Sciences - PHARMACOVIGILANCE 2025 (Germany)
- Biopharmaceuticals - Biotech-2025 (France)
- Biopharmaceuticals and Biotechnology - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Biopharmaceutics and Drug Disposition - Pharmaceutica-2025 (Canada)
- Biosimilars - Biotech-2025 (France)
- Biosimilars Approval to Biogenerics in Clinical Practice - Eurobiosimilars 2025 (France)
- Biosimilars Development in Markets - Eurobiosimilars 2025 (France)
- Biosimilars Market and Cost Analysis - Eurobiosimilars 2025 (France)
- Biosimilars Research Pipeline - Eurobiosimilars 2025 (France)
- Biotechnology and Biopharmaceuticals - PHARMA CONFERENCE-2025 (France)
- Cancer Biotechnology - Biotech-2025 (France)
- Cancer Clinical Research Progress - Clinical Trials Congress-2025 (France)
- Cardiac Arrhythmias and Pharmacotherapy - Cardiovascular-2025 (France)
- Cardio protective Agents: Mechanisms and Applications - Cardiovascular-2025 (France)
- Cardio Vascular Pharmacology - Pharmacology 2025 (France)
- Cardiovascular Drug Safety and Toxicology - Cardiovascular-2025 (France)
- Cardiovascular Pharmacology in Special Populations - Cardiovascular-2025 (France)
- Challenges in Biosimilars Pharmacovigilance - Eurobiosimilars 2025 (France)
- Challenges in Drug Formulation and Stability - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Challenges In Pharmaceutical Formulations - Pharmatech 2025 (Canada)
- Chemical and Analytical Strategies for Biosimilars - Eurobiosimilars 2025 (France)
- Chemical Synthesis and Catalysis - PHARMAKON 2025 (Spain)
- Chemo genomics - PHARMAKON 2025 (Spain)
- Chromatography & Separation Techniques - PHARMAKON 2025 (Spain)
- Classification of pain relief analgesics - Pain Management 2025 (Switzerland)
- Clinical and Hospital Pharmacy - PHARMACEUTICAL SCIENCES 2025 (France)
- Clinical and Hospital Pharmacy - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Clinical and Hospital Pharmacy - PHARMA CONFERENCE-2025 (France)
- Clinical and Hospital Pharmacy - Future Pharma 2025 (Netherlands)
- Clinical and Medical Case Reports - Pharma Europe 2025 (Italy)
- Clinical Data & Analytics Strategies - Clinical Trials Congress-2025 (France)
- Clinical Pharmacology & Receptor Therapy - Clinical Trials Congress-2025 (France)
- Clinical Pharmacy - Pharma Europe 2025 (Italy)
- Clinical Pharmacy and Pharmacotherapeutics - Pharmacology 2025 (France)
- Clinical Pharmacy and Pharmacy Practices - MedTech-2025 (Switzerland)
- Clinical Pharmacy and Therapeutics - PHARMACEUTICAL SCIENCES 2025 (France)
- Clinical Research & Clinical Trials - PHARMA CONFERENCE-2025 (France)
- Clinical Research and Drug Development - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Clinical Research Statistics - Pharmacology 2025 (France)
- Clinical Trial Auditing Innovations - Clinical Trials Congress-2025 (France)
- Clinical Trial Efficiency Factors - Clinical Trials Congress-2025 (France)
- Clinical Trials - Clinical Trials Congress-2025 (France)
- Clinical Trials - Personalizedmedicine-2025 (Switzerland)
- Clinical Trials & Safety Monitoring - Clinical Trials Congress-2025 (France)
- Clinical trials and Pharmacovigilance - MedTech-2025 (Switzerland)
- Clinical Trials on Various Disorders - PHARMACOVIGILANCE 2025 (Germany)
- Computational Chemistry and Molecular Modeling - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Computer Assisted Drug Design - Biotech-2025 (France)
- Computer-Aided Drug Design - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Consequences of Brexit on Biosimilars - Eurobiosimilars 2025 (France)
- COVID-19 and Drug Repurposing - PHARMA CONFERENCE-2025 (France)
- Current Agency Expectations for Approval for Biosimilars - Eurobiosimilars 2025 (France)
- Current Challenges in Developing Biosimilars - Eurobiosimilars 2025 (France)
- Cutting-edge Imaging Research - Clinical Trials Congress-2025 (France)
- Data Analytics - Personalizedmedicine-2025 (Switzerland)
- Data Quality Management and Analysis - PHARMACOVIGILANCE 2025 (Germany)
- Decentralized Trial Models - Clinical Trials Congress-2025 (France)
- Diagnostics & Medical Devices - Biotech-2025 (France)
- Digital Health - Personalizedmedicine-2025 (Switzerland)
- Digital Health and Telemedicine - PHARMA CONFERENCE-2025 (France)
- Digital Marketing in Pharma Industry - Future Pharma 2025 (Netherlands)
- Digital Pharma - PHARMACEUTICAL SCIENCES 2025 (France)
- Digital Pharma - Pharmatech 2025 (Canada)
- Disease Prevention - Personalizedmedicine-2025 (Switzerland)
- Diversity in Industrial Clinical Trials and Clinical Research - PHARMACOVIGILANCE 2025 (Germany)
- Drug Delivery & Blood-Brain Barrier - Clinical Trials Congress-2025 (France)
- Drug Delivery and Development - Eurobiosimilars 2025 (France)
- Drug Delivery and Gene Therapy - Pharmaceutica-2025 (Canada)
- Drug Delivery for Cardiovascular Diseases - Pharmaceutica-2025 (Canada)
- Drug Delivery in Cancer Therapy - Pharmaceutica-2025 (Canada)
- Drug Delivery in Infectious Diseases - Pharmaceutica-2025 (Canada)
- Drug Delivery Systems - Pharma Europe 2025 (Italy)
- Drug Delivery Techniques - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Drug Design, Discovery and Development - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Drug Development - PHARMACEUTICAL SCIENCES 2025 (France)
- Drug Development - PHARMAKON 2025 (Spain)
- Drug Discovery - PHARMACEUTICAL SCIENCES 2025 (France)
- Drug Discovery and Development - Future Pharma 2025 (Netherlands)
- Drug Discovery and Development - Pharmatech 2025 (Canada)
- Drug discovery and NCEs - MedTech-2025 (Switzerland)
- Drug Formulation - PHARMACEUTICAL SCIENCES 2025 (France)
- Drug Metabolism - PHARMAKON 2025 (Spain)
- Drug Product Manufacturing - Pharmatech 2025 (Canada)
- Drug Regulations - Pharma Europe 2025 (Italy)
- Drug Repurposing in Cardiovascular Medicine - Cardiovascular-2025 (France)
- Drug Safety Testing - Pharmacology 2025 (France)
- Drug Screening and Discovery - Pharmacology 2025 (France)
- Drug Targeting and Design - Pharmaceutica-2025 (Canada)
- Drug Targeting and Design - Pharmatech 2025 (Canada)
- Drug Targeting and Design - PHARMACEUTICA 2025 (Germany)
- Ecopharmacovigilance - Pharmacology 2025 (France)
- Electronic Health Records (EHRs) - Personalizedmedicine-2025 (Switzerland)
- Emerging Antithrombotic Therapies - Cardiovascular-2025 (France)
- Emerging Biosimilars in Therapeutics - Eurobiosimilars 2025 (France)
- Endothelial Nitric Oxide and Cardiovascular Health - Cardiovascular-2025 (France)
- Entrepreneurs Investment Meet - PHARMACEUTICAL SCIENCES 2025 (France)
- Environmental Catalysis and Green Chemistry - PHARMAKON 2025 (Spain)
- Epigenetic Therapies in Cancer - PHARMA CONFERENCE-2025 (France)
- Ethno pharmacy - PHARMAKON 2025 (Spain)
- Forensic Toxicology - Pharmacology 2025 (France)
- Formulation Strategies for Follow-on Biologics - Eurobiosimilars 2025 (France)
- Formulations and NNDS - MedTech-2025 (Switzerland)
- Generics versus Big Pharma - PHARMACEUTICAL SCIENCES 2025 (France)
- Genetic Testing - Personalizedmedicine-2025 (Switzerland)
- Genomics - Personalizedmedicine-2025 (Switzerland)
- Genotoxicity - PHARMAKON 2025 (Spain)
- Globalization of Biosimilars - Eurobiosimilars 2025 (France)
- Globalized Pharma Sector - PHARMACEUTICAL SCIENCES 2025 (France)
- Good Pharmacovigilance Practice - PHARMACOVIGILANCE 2025 (Germany)
- Green and Community Pharmacy - Future Pharma 2025 (Netherlands)
- Green Chemistry in Pharmaceutical Development - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Health Equity - Personalizedmedicine-2025 (Switzerland)
- Hereditary Angioedema Research - Clinical Trials Congress-2025 (France)
- Hydrogel-Based Delivery for Diabetes - PHARMA CONFERENCE-2025 (France)
- Immunopharmacology - Pharmacology 2025 (France)
- Industrial and Physical Pharmacy - PHARMACEUTICAL SCIENCES 2025 (France)
- Industrial Bioproceses for Drug Production and Development - Biotech-2025 (France)
- Industrial Pharmacy - Pharma Europe 2025 (Italy)
- Industrial Pharmacy and Physical pharmacy - Future Pharma 2025 (Netherlands)
- Innovations in Heart Failure Pharmacotherapy - Cardiovascular-2025 (France)
- Innovations In Pharmaceutical Technology - Pharmatech 2025 (Canada)
- Innovative Clinical Approach in Biosimilars - Eurobiosimilars 2025 (France)
- Innovative Drug Design and Discovery - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Intellectual Property Rights - Eurobiosimilars 2025 (France)
- Interventional Pain Management - Pain Management 2025 (Switzerland)
- Legal Issues and BPCI Act - Eurobiosimilars 2025 (France)
- Lifestyle Medicine - Personalizedmedicine-2025 (Switzerland)
- Lipids and Cholesterol Management in Cardiovascular Disease - Cardiovascular-2025 (France)
- Mass Spectrometry - PHARMAKON 2025 (Spain)
- Medical Devices for Drug Delivery - PHARMACEUTICA 2025 (Germany)
- Medicinal Chemistry - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Medicinal Chemistry and Targeted Therapies - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Medicinal Chemistry: Physical Properties and Drug Design - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Medico Marketing - PHARMACEUTICAL SCIENCES 2025 (France)
- Microbial & Environmental Biotechnology - Biotech-2025 (France)
- Molecualr Biotechnology - Biotech-2025 (France)
- Molecular and Cellular Pharmacology - PHARMAKON 2025 (Spain)
- Molecular and Clinical Pharmacology - Pharmacology 2025 (France)
- Molecular Mechanisms of Cardiovascular Pharmacology - Cardiovascular-2025 (France)
- Monoclonal Antibody Biosimilars - Eurobiosimilars 2025 (France)
- Nano medicine and Nanotechnology in Drug Delivery - Pharmaceutica-2025 (Canada)
- Nano particulate Drug Delivery Systems - PHARMACEUTICA 2025 (Germany)
- Nanomedicine and Biomedical Applications - PHARMACEUTICA 2025 (Germany)
- Nanomedicine and Nano Technology - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Nanomedicine in Cardiovascular Pharmacology - Cardiovascular-2025 (France)
- Nanotechnology in Drug Delivery - Pharma Europe 2025 (Italy)
- Nanotechnology in Drug Delivery Systems - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Nanotechnology in Drug Discovery - Clinical Trials Congress-2025 (France)
- Natural Products and Traditional Medicine - PHARMA CONFERENCE-2025 (France)
- Natural Products Chemistry - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Neuro Pharmacology - Pharmacology 2025 (France)
- Next-Gen Drug Design Techniques - Clinical Trials Congress-2025 (France)
- NMR in Rational Drug Design - PHARMAKON 2025 (Spain)
- Non-Pharmacological Approaches for Pain - Pain Management 2025 (Switzerland)
- Novel Drug Delivery Systems - Future Pharma 2025 (Netherlands)
- Novel Drug Delivery Systems, Biomarkers & Drug Targets - MedTech-2025 (Switzerland)
- Novel Drug Delivery Technologies - Pharmaceutica-2025 (Canada)
- Novel Target Drugs to the Treatment of Cancer - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Novel Targets in Hypertension Therapy - Cardiovascular-2025 (France)
- NSAIDs and Analgesics - Pain Management 2025 (Switzerland)
- Ocular Pharmacology - Pharmacology 2025 (France)
- Organic Chemistry and Inorganic Chemistry - PHARMAKON 2025 (Spain)
- Organic Chemistry in Pharmaceuticals - Clinical Trials Congress-2025 (France)
- Pain Management and Rehabilitation - Pain Management 2025 (Switzerland)
- Pain Medicine - Pain Management 2025 (Switzerland)
- Patient-Cantered Care - Personalizedmedicine-2025 (Switzerland)
- Peptide and Protein Drug Delivery - Pharmaceutica-2025 (Canada)
- Personalized Healthcare - Personalizedmedicine-2025 (Switzerland)
- Personalized Medicine in Cardiovascular Care - Cardiovascular-2025 (France)
- Pharma and Biotech Financial Outlook - PHARMACEUTICAL SCIENCES 2025 (France)
- Pharma and Biotech Financial Outlook - Future Pharma 2025 (Netherlands)
- Pharma Companies - Pharma Europe 2025 (Italy)
- Pharma Market Research - MedTech-2025 (Switzerland)
- Pharmaceutical Analysis - Future Pharma 2025 (Netherlands)
- Pharmaceutical Analysis - Pharmatech 2025 (Canada)
- Pharmaceutical Analysis - PHARMACEUTICA 2025 (Germany)
- Pharmaceutical Analysis: Analytical Methods - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Pharmaceutical and healthcare Industry - Future Pharma 2025 (Netherlands)
- Pharmaceutical Biotechnology - Pharma Europe 2025 (Italy)
- Pharmaceutical Chemistry - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Pharmaceutical Chemistry - Pharma Europe 2025 (Italy)
- Pharmaceutical Chemistry - Future Pharma 2025 (Netherlands)
- Pharmaceutical Chemistry - Pharmatech 2025 (Canada)
- Pharmaceutical Chemistry - PHARMACEUTICA 2025 (Germany)
- Pharmaceutical Engineering - PHARMACEUTICAL SCIENCES 2025 (France)
- Pharmaceutical Engineering - Pharma Europe 2025 (Italy)
- Pharmaceutical Formulation - PHARMACEUTICA 2025 (Germany)
- Pharmaceutical Formulation Advances - Clinical Trials Congress-2025 (France)
- Pharmaceutical Formulations - Pharma Europe 2025 (Italy)
- Pharmaceutical Industry - Pharmatech 2025 (Canada)
- Pharmaceutical Industry and Market Trends - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Pharmaceutical Manufacturing - PHARMACEUTICA 2025 (Germany)
- Pharmaceutical Manufacturing and Pharmacoeconomics - MedTech-2025 (Switzerland)
- Pharmaceutical Manufacturing, Scale Up and Tech transfer - MedTech-2025 (Switzerland)
- Pharmaceutical Marketing - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Pharmaceutical Microbiology - Pharma Europe 2025 (Italy)
- Pharmaceutical Microbiology and Biotechnology - PHARMA CONFERENCE-2025 (France)
- Pharmaceutical Nanotechnology - PHARMACEUTICAL SCIENCES 2025 (France)
- Pharmaceutical Nanotechnology - Pharma Europe 2025 (Italy)
- Pharmaceutical Nanotechnology - PHARMACEUTICA 2025 (Germany)
- Pharmaceutical Packaging and Logistics - MedTech-2025 (Switzerland)
- Pharmaceutical Process Validation - PHARMACEUTICAL SCIENCES 2025 (France)
- Pharmaceutical Research and Development - Pharmatech 2025 (Canada)
- Pharmaceutical Science - Pharmatech 2025 (Canada)
- Pharmaceutical sciences - PHARMACEUTICAL SCIENCES 2025 (France)
- Pharmaceutical Sciences - Pharma Europe 2025 (Italy)
- Pharmaceutical Sciences - MedTech-2025 (Switzerland)
- Pharmaceutical Supply Chain Optimization - PHARMACEUTICAL SCIENCES 2025 (France)
- Pharmaceutical Technology - Clinical Trials Congress-2025 (France)
- Pharmaceuticals and Cosmetics - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Pharmaceuticals and Nutraceuticals - PHARMAKON 2025 (Spain)
- Pharmaceutics - Pharma Europe 2025 (Italy)
- Pharmaceutics & Pharmacotherapeutics - Future Pharma 2025 (Netherlands)
- Pharmaceutics and Pharmacotherapeutics - Pharmatech 2025 (Canada)
- Pharmacists Role in Patient Safety - Pharmatech 2025 (Canada)
- Pharmacodynamics - PHARMAKON 2025 (Spain)
- Pharmacoeconomics - MedTech-2025 (Switzerland)
- Pharmacogenetics - Personalizedmedicine-2025 (Switzerland)
- Pharmacogenetics & Pharmacogenomics - PHARMA CONFERENCE-2025 (France)
- Pharmacogenomics - PHARMAKON 2025 (Spain)
- Pharmacogenomics - Personalizedmedicine-2025 (Switzerland)
- Pharmacogenomics and Pharmacoepidemiology - MedTech-2025 (Switzerland)
- Pharmacogenomics in Cardiovascular Medicine - Cardiovascular-2025 (France)
- Pharmacognosy - Pharma Europe 2025 (Italy)
- Pharmacognosy - PHARMAKON 2025 (Spain)
- Pharmacokinetics - PHARMAKON 2025 (Spain)
- Pharmacokinetics and Pharmacodynamics - Pharmaceutica-2025 (Canada)
- Pharmacokinetics and Pharmacodynamics - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Pharmacokinetics and Pharmacodynamics - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Pharmacokinetics and Pharmacodynamics in Cardiology - Cardiovascular-2025 (France)
- Pharmacokinetics and Pharmacodynamics in Drugs - PHARMACEUTICA 2025 (Germany)
- Pharmacological Approaches for Pain - Pain Management 2025 (Switzerland)
- Pharmacological Approaches to Myocardial Ischemia - Cardiovascular-2025 (France)
- Pharmacological Management of Cardiovascular Risk Factors - Cardiovascular-2025 (France)
- Pharmacological Sciences - Pharma Europe 2025 (Italy)
- Pharmacology - Pharmatech 2025 (Canada)
- Pharmacology - Pharmacology 2025 (France)
- Pharmacology and Toxicology - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Pharmacology and Toxicology - MedTech-2025 (Switzerland)
- Pharmacovigilance and Drug Safety - PHARMA CONFERENCE-2025 (France)
- Pharmacovigilance and Risk Management - PHARMACOVIGILANCE 2025 (Germany)
- Pharmacovigilance Significance & Scope - PHARMACOVIGILANCE 2025 (Germany)
- Pharmacovigilance Significance and Scope - Pharmacology 2025 (France)
- Pharmacy Development Services - Pharma Europe 2025 (Italy)
- Pharmacy Education and Practice - PHARMACEUTICAL SCIENCES 2025 (France)
- Pharmacy Practices and its Challenges - PHARMACOVIGILANCE 2025 (Germany)
- Photochemistry and Phytopharmaceuticals - PHARMAKON 2025 (Spain)
- Population Health - Personalizedmedicine-2025 (Switzerland)
- Post-Marketing Surveillance Insights - Clinical Trials Congress-2025 (France)
- Post-Trial Closed Communities - Clinical Trials Congress-2025 (France)
- Pre-clinical and Clinical Trails - Pharmacology 2025 (France)
- Pre-Clinical and Clinical Trials - PHARMACOVIGILANCE 2025 (Germany)
- Precision Medicine - Personalizedmedicine-2025 (Switzerland)
- Purpose and Principles of GMP - PHARMACEUTICAL SCIENCES 2025 (France)
- QC & QA: Quality control and Quality assurance - MedTech-2025 (Switzerland)
- Quality by design (QbD) approach - MedTech-2025 (Switzerland)
- Quality Control and Regulatory Considerations in Drug Delivery Systems - Pharmaceutica-2025 (Canada)
- R&D Advancement: Road to New Medicines - PHARMACEUTICAL SCIENCES 2025 (France)
- Rational Design of Non-Oral Drugs - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Rational Drug Design and Molecular Modeling - PHARMA CONFERENCE-2025 (France)
- Real-World Evidence in Clinical Trials - Pharma Europe 2025 (Italy)
- Recent Advancements in Medicinal Pharma - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Recent Advances in Pharmacology and Toxicology - Pharmacology 2025 (France)
- Recent Advances in Pharmacology and Toxicology - Pharmacology 2025 (France)
- Regenerative Medicine - Pain Management 2025 (Switzerland)
- Regulatory Affairs and Drug Safety - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Regulatory Affairs and Intellectual Property Rights - Future Pharma 2025 (Netherlands)
- Regulatory Affairs and Quality Assurance in Pharmaceutics - Pharmaceutica-2025 (Canada)
- Regulatory Authority Compliance - MedTech-2025 (Switzerland)
- Regulatory Requirements for Pharmaceuticals - PHARMACEUTICAL SCIENCES 2025 (France)
- Regulatory Updates on Biosimilars - Eurobiosimilars 2025 (France)
- Role of Gut Microbiome in Cardiovascular Health - Cardiovascular-2025 (France)
- Role of Inflammation in Cardiovascular Diseases - Cardiovascular-2025 (France)
- Safety Pharmacology - Pharmacology 2025 (France)
- Smart Drug Delivery Systems - Pharmatech 2025 (Canada)
- Smart Drug Delivery Systems - PHARMACEUTICA 2025 (Germany)
- Smart Polymers for Drug Delivery - Pharmaceutica-2025 (Canada)
- Sustainability and Global Health Biotechnology - Biotech-2025 (France)
- Synthetic and Bioorganic Chemistry - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Targeted Drug Delivery and Controlled Release Systems - PHARMA CONFERENCE-2025 (France)
- Targeted Therapies - Personalizedmedicine-2025 (Switzerland)
- Targeted Therapies in Cardiovascular Regeneration - Cardiovascular-2025 (France)
- Targeting the Renin-Angiotensin-Aldosterone System (RAAS) - Cardiovascular-2025 (France)
- Technology in Pharma Sciences - MedTech-2025 (Switzerland)
- Telemedicine - Personalizedmedicine-2025 (Switzerland)
- The Future of Pharma R&D - Future Pharma 2025 (Netherlands)
- Toxicology - Pharmacology 2025 (France)
- Translational Research - Personalizedmedicine-2025 (Switzerland)
- USFDA Approved Biosimilars - Eurobiosimilars 2025 (France)
- Vaccine Delivery Systems - Pharmaceutica-2025 (Canada)
- Vaccine Design and Drug Design - PHARMA CONFERENCE-2025 (France)
- Vaccine Drug Delivery Systems - PHARMACEUTICA 2025 (Germany)
- Vascular Pharmacology: Focus on Endothelial Dysfunction - Cardiovascular-2025 (France)
- Wearable Drug Delivery Systems - PHARMA CONFERENCE-2025 (France)